|
Volumn 42, Issue 10, 2006, Pages 817-822
|
Effect of combined treatment methods on quality of life in patients with pancreatic cancer;Kasos vezio kompleksinio gydymo itaka ligoniu gyvenimo kokybei.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
FLUOROURACIL;
GEMCITABINE;
RADIOSENSITIZING AGENT;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EVALUATION;
FEMALE;
FOLLOW UP;
HEALTH STATUS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
PANCREAS;
PANCREAS TUMOR;
PATHOLOGY;
PROSPECTIVE STUDY;
QUALITY OF LIFE;
QUESTIONNAIRE;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIMETABOLITES, ANTINEOPLASTIC;
COMBINED MODALITY THERAPY;
DATA INTERPRETATION, STATISTICAL;
DEOXYCYTIDINE;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HEALTH STATUS;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PANCREAS;
PANCREATIC NEOPLASMS;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
QUESTIONNAIRES;
RADIATION-SENSITIZING AGENTS;
RADIOTHERAPY DOSAGE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 39049184776
PISSN: None
EISSN: 16489144
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|